Home > Category > Signaling Pathways > Membrane Transporter/Ion Channel > Sodium Channel > Ropivacaine hydrochloride monohydrate

Ropivacaine hydrochloride monohydrate

ChemLeader 98+%

Catalog No：CL2947 CAS No.：132112-35-7 MDLNo： Formula：C17H29ClN2O2 MW：328.88

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Ropivacaine hydrochloride monohydrate
CAS	132112-35-7
Formula	C17H29ClN2O2
MW	328.88
Appearance	White to off-white powder
Storage condition	4°C, sealed storage, away from moisture

Product details

Ropivacaine hydrochloride monohydrate (LEA-103 HCl) is an anaesthetic agent and blocks impulse conduction in nerve fibres through inhibiting sodium ion influx reversibly.

Related literature

Epidural sustained release ropivacaine prolongs anti-allodynia and anti-hyperalgesia in developing and established neuropathic pain.

PMID: 25617901 PMCID: PMC4305322 DOI: 10.1371/journal.pone.0117321

Ropivacaine: a review of its use in regional anaesthesia and acute pain management.

PMID: 16392884 DOI: 10.2165/00003495-200565180-00013

Ropivacaine Inhibits Pressure-Induced Lung Endothelial Hyperpermeability in Models of Acute Hypertension.

PMID: 30822427 DOI: 10.1016/j.lfs.2019.02.053

The inhibitory effects of bupivacaine, levobupivacaine, and ropivacaine on K2P (two-pore domain potassium) channel TREK-1.

PMID: 23797625 DOI: 10.1007/s00540-013-1661-1